Establishment and characterization of colon carcinoma and renal cell carcinoma primary cultures

Cancer Biotherapy and Radiopharmaceuticals

Volumn 15, Issue 2, 2000, Pages 169-174

  Trojaneck, Beate ^a   Niemitz, Sigrun ^a   Micka, Bettina ^b   Lefterova, Petja ^b   Blasczyk, Rainer ^c   Scheffold, Christian ^d   Huhn, Dieter ^a   Schmidt Wolf, Ingo G H ^b,e  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Colon carcinoma; Gene transfer; HLA; Renal cell carcinoma

Indexed keywords

HLA ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; GENE TRANSFER; HLA TYPING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

EID: 0034101030     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2000.15.169     Document Type: Article

References (16)

1. Kemner W, Schlag P, Brossmer R. A rapid and simple procedure for dissociation of tumor tissue from the human colon. J Cancer Res Clin Oncol 1987; 113:40-401.
2. Weiser MM. Intestinal epithelial cell surface membrane glykoprotein synthesis. J Biol Chem 1973; 248:2536-2541.
3. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313:812-815.
4. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation in cytotoxicity assays. J Immunol. Methods 1983; 65:55-57.
5. Schadendorf D, Tiedemann KH, Haas N et al. Detection of human papilloma viruses in paraffin-embedded condylomata accuminata - comparision of immunohistochemistry, in situ hybridization and polymerase chain reaction. J. Invest. Dermatol. 1991; 97:549-554.
6. Blasczyk R. New HLA typing methods. In: Huhn D (ed), New Diagnostic Methods in Oncology and Hematology, Springer Verlag, Berlin 1998; 143-195.
7. Gansbacher B, Houghton, A, Livingston P. Clinical Protocol: A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma. Human Gene Therapy 1992; 3:677-690.
8. Arienti F, Belli F, Rivoltini L et al. Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2. Cancer Immunol Immunother. 1993; 36:315-322.
9. Schmidt-Wolf GD, Schmidt-Wolf IGH. Cancer and gene therapy. Ann Hematol 1996; 73:207-218.
10. Murphy WJ, et al. Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J ofClin Invest 1993; 92:1918-1924.
11. Schmidt-Wolf G, Schmidt-Wolf IGH. Cytokines and clinical gene therapy. Europ J Immunol 1995; 25(4):1137-1140.
12. Colombo MP, Forni G. Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol. Today 1994; 15:48-51.
13. Finke S, Trojaneck B, Moeller P, Schadendorf D, Neubauer A, Huhn D, Schmidt-Wolf IGH. Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene. Cancer Gene Ther 1997; 4(4):260-268.
14. Schmidt-Wolf G, Schmidt-Wolf IGH. Cytokines and gene therapy. Immunol Today 1995; 16:173-175.
15. Miller AR, McBride WH, Dubinett SM et al. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: Comparison of immunologic properties with interleukin-2. Blood 1993; 82:3686-3694.
16. + T cell-dependent tumor rejection. J Exp Med 1991; 174:1291-1298.